Table 1– Age and comorbid disorders of rhinovirus-positive patients with respiratory illness
Rhinovirus-positive samplesRhinovirus infectionp-value
Visit 1 onlyVisit 1 and visit 2p-valueProlongedRe-infectionp-valueVisit 1 only versus prolongedVisit 1 only versus re-infection
Patients n42221611
Age years49 (35–61)54 (34–71)0.3272 (44–78)48 (30–61)0.120.070.62
Comorbidity#421
 COPD30 (7.1)6 (28.6)0.0041 (16.7)3 (27.3)1.000.370.04
 Asthma42 (10)5 (23.8)0.0604 (36.4)0.241.000.02
 Other lung disease6 (1.4)1 (4.8)0.2901 (9.1)1.001.000.17
 Cardiovascular34 (8.1)3 (14.3)0.412 (33.3)00.110.081.00
 Diabetes26 (6.2)1 (4.8)1.0001 (9.1)1.001.000.51
 Previous hospitalisation for RI16 (3.8)2 (9.5)0.2102 (18.2)0.521.000.07
 Allergic disease73 (17.4)6 (28.6)0.241 (16.7)4 (36.4)0.601.000.11
  • Data are presented as median (interquartile range) or n (%), unless otherwise stated. COPD: chronic obstructive pulmonary disease; RI: respiratory infection. p-values were calculated using the Pearson Chi-squared or Fisher's Exact test, except for the median age, which was calculated using the Mann-Whitney U –test; #: some patients had more than one comorbidity and data on comorbidities were lacking for one patient. Bold signifies statistical significance.